https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: the ELSIE Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14133 Wed 11 Apr 2018 16:56:23 AEST ]]> Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10494 Sat 24 Mar 2018 08:08:58 AEDT ]]>